Literature DB >> 11722312

Oestrogen withdrawal associated psychoses.

V Mahé1, A Dumaine.   

Abstract

OBJECTIVE: Oestrogen withdrawal has been hypothesized as playing a causal role in puerperal psychoses. However, oestrogen withdrawal exists in conditions others than puerperium. We searched the published case reports where a decrease in oestrogen levels not occurring during puerperium was associated with a psychotic disorder, in order to evaluate the relevance of this hypothesis. These cases were defined as oestrogen withdrawal associated psychoses.
METHOD: A systematic research of the literature was conducted for the period 1960-2000.
RESULTS: We identified 26 observations reporting an association between a psychotic disorder and a phase of oestrogen withdrawal. Psychotic episodes were short and reversible with recurrences reported when oestrogen withdrawal recurred. Puerperal psychosis was frequently reported in the history of patients.
CONCLUSION: The oestrogen withdrawal hypothesis can be extended to certain psychotic episodes not occurring during in puerperium. This provides an additional argument for the clinical relevance of oestrogen withdrawal in puerperal and related psychoses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722312     DOI: 10.1034/j.1600-0447.2001.00288.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  14 in total

1.  Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).

Authors:  Nilfer Sahin; Hatice Altun; Ergül Belge Kurutaş; Ebru Fındıklı
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

2.  Timing of menarche and abnormal hippocampal connectivity in youth at clinical-high risk for psychosis.

Authors:  Katherine S F Damme; Ivanka Ristanovic; Teresa Vargas; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2020-04-30       Impact factor: 4.905

Review 3.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

Review 4.  Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  J Pharmacol Exp Ther       Date:  2016-10-27       Impact factor: 4.030

5.  Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?

Authors:  Seethalakshmi Ramanathan; Jean Miewald; Debra Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2015-03-14       Impact factor: 4.939

6.  [Exacerbation of a schizoaffective psychosis after in vitro fertilization with leuproreline acetate].

Authors:  F Abu-Tair; T Strowitzki; N Bergemann
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

Review 7.  An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature.

Authors:  Srinagesh Mannekote Thippaiah; Soumya Nagaraja; Badari Birur; Arnold W Cohen
Journal:  Psychopharmacol Bull       Date:  2018-03-13

8.  Are prenatal, obstetric, and infant complications associated with postpartum psychosis among women with pre-conception psychiatric hospitalisations?

Authors:  W L Hellerstedt; S M Phelan; S Cnattingius; C M Hultman; B L Harlow
Journal:  BJOG       Date:  2012-11-30       Impact factor: 6.531

9.  The potential role of oestrogens in relapse of recurrent affective psychosis.

Authors:  John Clifford; Jane Rowland
Journal:  JRSM Short Rep       Date:  2011-10-25

10.  The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia.

Authors:  Emily Hayes; Emorfia Gavrilidis; Jayashri Kulkarni
Journal:  Schizophr Res Treatment       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.